Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
A new stroke prevention drug developed by Bayer and Johnson & Johnson proved a safe alternative to the standard treatment, lifting their chances of entering a $12 billion plus market, the German drug company said.
A late-stage study called Rocket-AF showed that the Xarelto pill was as good as the established warfarin pill at reducing the risk of strokes due to a form of irregular heartbeat that is common among the elderly, Bayer said on Sunday. Get the full story »
Bristol-Myers Squibb Co. says it is recalling eight production lots of its anti-clotting drug Coumadin because the amount of the active ingredient in the drug could change. Get the full story »
Bristol-Myers Squibb has recalled some of its samples of Coumadin, a popular blood thinner, because of a variation in an ingredient that stabilizes the active drug.
A spokeswoman for the company said 8 lots, or 144,700 samples, each of which contained 10 tablets, have been recalled. The affected lots were distributed only as samples, she said. Get the full story »
